ES2120573T3 - 24-epi-1-alfa-hidroxivitamina d2 para tratar la osteoporosis. - Google Patents

24-epi-1-alfa-hidroxivitamina d2 para tratar la osteoporosis.

Info

Publication number
ES2120573T3
ES2120573T3 ES94305104T ES94305104T ES2120573T3 ES 2120573 T3 ES2120573 T3 ES 2120573T3 ES 94305104 T ES94305104 T ES 94305104T ES 94305104 T ES94305104 T ES 94305104T ES 2120573 T3 ES2120573 T3 ES 2120573T3
Authority
ES
Spain
Prior art keywords
hydroxivitamine
epi
alpha
treat osteoporosis
osteoporosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94305104T
Other languages
English (en)
Inventor
Hector F Deluca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Application granted granted Critical
Publication of ES2120573T3 publication Critical patent/ES2120573T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBE UN METODO PARA TRATAMIENTO DE LA OSTEOPOROSIS QUE CONSISTE EN LA ADMINISTRACION DE UNA CANTIDAD EFECTIVA DE 24-EPI-1ALFA-HIDROXIVITAMINA D2.
ES94305104T 1993-07-13 1994-07-13 24-epi-1-alfa-hidroxivitamina d2 para tratar la osteoporosis. Expired - Lifetime ES2120573T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9122393A 1993-07-13 1993-07-13

Publications (1)

Publication Number Publication Date
ES2120573T3 true ES2120573T3 (es) 1998-11-01

Family

ID=22226681

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94305104T Expired - Lifetime ES2120573T3 (es) 1993-07-13 1994-07-13 24-epi-1-alfa-hidroxivitamina d2 para tratar la osteoporosis.

Country Status (4)

Country Link
EP (1) EP0634173B1 (es)
JP (1) JPH0753384A (es)
DE (1) DE69413325T2 (es)
ES (1) ES2120573T3 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19916419B4 (de) * 1999-04-08 2005-06-16 Schering Ag Kombinationspräparat aus Vitamin-D-Metaboliten oder Vitamin-D-Analoga und einem Östrogenpartialagonisten zur Behandlung von Osteoporose

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
CA1341408C (en) * 1988-08-02 2002-12-10 Charles W. Bishop Method for treating and preventing loss of bone mass
US4973584A (en) * 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives

Also Published As

Publication number Publication date
DE69413325T2 (de) 1999-04-29
DE69413325D1 (de) 1998-10-22
JPH0753384A (ja) 1995-02-28
EP0634173B1 (en) 1998-09-16
EP0634173A1 (en) 1995-01-18

Similar Documents

Publication Publication Date Title
ES2114487B1 (es) Mezcla estabilizante sinergistica.
FI962445A7 (fi) Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
GEP20033044B (en) Method for Treating Atherosclerosis
ES2168766T3 (es) Preparacion farmaceutica que incluye el propeptido vwf.
MY106263A (en) Method for the treatment or prevention of intrinsically aged skin with retinoids
GT199800177A (es) Combinacion eficaz para el tratamiento de la impotencia .
BR9509006A (pt) Composiçao para aplicaçao tópica na pele composiçao farmacêutica uso de um inibidor de síntese de colesterol e processo para o tratamento mitigaçao ou prevençao de distúrbios de pele
CA2002859A1 (en) Method of treating epithelial disorders
SE8402242L (sv) Biocid
ZA855997B (en) Vitamin d3 derivatives
MX9703944A (es) Metodo para usar derivados de triaril-etileno en el tratamiento y prevencion de osteoporosis.
ES2125463T3 (es) Procedimiento para la preparacion de derivados de acido n-acetil neuraminico.
ES2124990T3 (es) Conversion de bisnoralcohol en bisnoraldehido.
EA199800866A1 (ru) Способ снятия боли
ES2187534T3 (es) Procedimiento para la preparacion de n-metil-3-(metil-4-piperi dinil)-14-indol-5-etanosulfonamida.
NZ503372A (en) Chemical supplementation of bone by exposing bone to a therapeutic compound and applying a potential difference across the bone or tissue
ES2084878T3 (es) Sal colina de diclofenac, un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
ES2120573T3 (es) 24-epi-1-alfa-hidroxivitamina d2 para tratar la osteoporosis.
ES2180643T3 (es) Procedimiento para tratar la disfuncion cognitiva.
UA19335A (uk) Спосіб приготуваhhя засобу для лікуваhhя хвороб типу псоріазу
ES541436A0 (es) Procedimiento para preparar un agente farmaceutico que con- tiene un inhibidor de la enzima convertidora de angiotensina
AP9801416A0 (en) Method Of treating a plant disease.
AU562828B2 (en) Morphine-vitamin b12 analgesic treatment
MX9304878A (es) Uso de un azaspirano substituido en la fabricacion de un medicamento para utilizarse en el tratamiento de psoriasis.
AU566411B2 (en) Terphenyl derivatives

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 634173

Country of ref document: ES